These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 78584)

  • 1. [Evaluation of efficiency of the drug treatment of patients with toxic goiter].
    Zelinskiĭ BA; Slobodnianik OA
    Vrach Delo; 1978 Apr; (4):115-8. PubMed ID: 78584
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes of the blood kallikrein-kinin system in patients with diffuse toxic goiter under the influence of thyrostatic therapy and prodectin].
    Matiashina GI
    Vrach Delo; 1989 Apr; (4):31-3. PubMed ID: 2474220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of lithium carbonate in treating patients with diffuse toxic goiter].
    Balabolkin MI; Petunina NA; Tsaguriia KG
    Klin Med (Mosk); 1990 Oct; 68(10):68-9. PubMed ID: 1706446
    [No Abstract]   [Full Text] [Related]  

  • 4. [Complex treatment of toxic goiter].
    Kal'chenko II; Nechiporenko FP
    Sov Med; 1973 Oct; 36(10):99-102. PubMed ID: 4133131
    [No Abstract]   [Full Text] [Related]  

  • 5. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
    Berg GE; Michanek AM; Holmberg EC; Fink M
    J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism].
    Bürgi U; Gerber H; Peter HJ
    Schweiz Med Wochenschr; 1995 Aug; 125(31-32):1489-94. PubMed ID: 7545825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Criteria for recovery from diffuse toxic goiter].
    Baranov VG; Nikolaenko NF
    Klin Med (Mosk); 1970 Apr; 48(4):50-3. PubMed ID: 4193305
    [No Abstract]   [Full Text] [Related]  

  • 8. Antithyroid drugs and radioactive iodine. Fifteen years' experience with Graves' disease.
    Reynolds LR; Kotchen TA
    Arch Intern Med; 1979 Jun; 139(6):651-3. PubMed ID: 87156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease and toxic multinodular goiter.
    Gedik O; Ozdemir T; Akalin S
    Isr J Med Sci; 1991 Jul; 27(7):361-4. PubMed ID: 1712765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
    Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remission of Graves' hyperthyroidism treated with methimazole.
    Bolaños F; González-Ortiz M; Durón H; Sánchez C
    Rev Invest Clin; 2002; 54(4):307-10. PubMed ID: 12415954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and morphologic comparisons in toxic goiter].
    Grigor'ev PIa; Samoteĭkin MA; Korolev RV
    Arkh Patol; 1967; 29(6):55-8. PubMed ID: 4178179
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current therapy of complicated forms of diffuse toxic goiter].
    Starkova NT; Kotova GA
    Ter Arkh; 1980; 52(8):56-9. PubMed ID: 6167001
    [No Abstract]   [Full Text] [Related]  

  • 14. [Graves-Basedow disease, factors that influence in their relapse].
    Martí Cabané J
    An Med Interna; 2003 Jul; 20(7):388. PubMed ID: 12951976
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thyroid function and the state of the hypothalamus-hypophysis-thyroid in patients with diffuse toxic goiter after treatment].
    Aliakparova ASh
    Sov Med; 1973 Dec; 36(12):45-8. PubMed ID: 4130665
    [No Abstract]   [Full Text] [Related]  

  • 16. Experience with carbimazole in the treatment of the hyperthyroidism of Graves' disease in Nigerian patients.
    Modebe O
    Afr J Med Med Sci; 1995 Dec; 24(4):347-51. PubMed ID: 8886149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Conservative treatment of diffuse toxic goiter].
    Potin VV
    Sov Med; 1979 Jun; (6):87-91. PubMed ID: 89703
    [No Abstract]   [Full Text] [Related]  

  • 18. The safety and efficacy of antithyroid drugs.
    Azizi F
    Expert Opin Drug Saf; 2006 Jan; 5(1):107-16. PubMed ID: 16370960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responsiveness to thyrotropin releasing hormone and thyroid suppressibility in Graves' disease patients remaining in remission after antithyroid drug therapy.
    Rajatanavin R; Mahatumarat P; Poochanugool L; Kumpolpunth S; Himathongkam T
    J Med Assoc Thai; 1981 Jan; 64(1):11-8. PubMed ID: 6163837
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hyperthyroidism in Graves' disease--antithyroid drug treatment].
    Schumm-Draeger PM
    Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():41-5. PubMed ID: 10355049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.